Form 4: Waystar CTO Exercises Stock Options and Sells Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Waystar Holding Corp.'s Chief Technology Officer, Christopher L. Schremser, exercised stock options and subsequently sold 8,623 shares of common stock for approximately $40.58 per share, as part of a pre-scheduled 10b5-1 trading plan.
Summary
- Christopher L. Schremser, Chief Technology Officer of Waystar Holding Corp., engaged in a transaction on June 10, 2025.
- He exercised 8,623 stock options at an exercise price of $4.14 per share, acquiring 8,623 shares of common stock.
- Concurrently, he sold all 8,623 newly acquired shares of common stock at a weighted average price of $40.5761 per share.
- The sales occurred in multiple transactions ranging from $40.335 to $41.05 per share.
- These transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2024.
- Following these transactions, Mr. Schremser directly beneficially owns 438,044 shares of common stock and 120,732 stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that it was conducted under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling. It represents a routine liquidity event for an executive realizing value from vested equity compensation.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, negative information.
- The exercise of options at a low strike price ($4.14) and subsequent sale at a significantly higher market price ($40.5761) demonstrates a substantial personal gain for the CTO.
Negatives
- The sale of shares by a Chief Technology Officer, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces insider ownership.
Risks
- While not explicitly stated as a risk, insider selling, even under a 10b5-1 plan, can sometimes lead to negative investor sentiment if not properly understood, potentially impacting share price.
Future Outlook
The document, a Form 4 filing, does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing details a routine insider transaction (option exercise and sale) for a Chief Technology Officer. Such transactions are common across industries, particularly in technology and healthcare sectors where equity compensation is a significant part of executive pay. The use of a 10b5-1 plan is a standard practice for insiders to manage their equity holdings and avoid accusations of trading on material non-public information.
Comparison to Industry Standards
- This document is a standard SEC Form 4 filing reporting an insider transaction.
- The exercise of vested stock options and subsequent sale of shares is a common practice for executives to realize value from their equity compensation.
- The use of a Rule 10b5-1 plan is a widely adopted corporate governance practice to facilitate orderly insider trading and mitigate concerns about trading on inside information, aligning with best practices for executive liquidity management in publicly traded companies.
Stakeholder Impact
- Shareholders: The sale of shares by a key executive, even under a 10b5-1 plan, slightly reduces insider ownership, which some investors might view as a minor negative. However, the pre-planned nature of the sale typically lessens any negative perception.
- Employees: No direct impact on employees is indicated by this transaction.
Next Steps
- The document does not specify any future actions, events, or milestones for the company or the reporting person beyond the completion of the reported transaction.
Key Dates
| Date | Description |
|---|---|
| 12/06/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 06/10/2025 | Date of the stock option exercise and subsequent sale of common stock. |
| 06/11/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
| 11/01/2027 | Expiration date of the exercised stock options. |
Recommendation
holdKeywords
Waystar Holding Corp., WAY, SEC Form 4, Insider Trading, Stock Options, Share Sale, Christopher L. Schremser, Chief Technology Officer, 10b5-1 Plan, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.